Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
Lee Cheng Phua, Cheuk‐Wai Choi, Joseph T. Wu, et al.
Vaccine (2021) Vol. 39, Iss. 16, pp. 2255-2263
Closed Access | Times Cited: 11

Showing 11 citing articles:

Cost-effectiveness analysis of switching from a bivalent to a nonavalent HPV vaccination programme in China: a modelling study
Meng Gao, Shangying Hu, Xuelian Zhao, et al.
The Lancet Regional Health - Western Pacific (2025) Vol. 56, pp. 101499-101499
Open Access
Modelling epidemiological and economics processes – the case of cervical cancer
F Taeger, Lena Mende, Steffen Fleßa
Health Economics Review (2025) Vol. 15, Iss. 1
Open Access
Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
Brandon Chua, Li Min Lim, Joseph Ng, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1812-1812
Open Access | Times Cited: 8
Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting
Wichai Termrungruanglert, Nipon Khemapech, Apichai Vasuratna, et al.
Journal of Gynecologic Oncology (2024) Vol. 35, Iss. 6
Open Access | Times Cited: 2
Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region
Wanatpreeya Phongsamart, Pei‐Jen Lou, Isaya Sukarom, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
The cost-effectiveness of school-based interventions for chronic diseases: a systematic review
George C. S. Lin, Kalin Werner, Ada Alqunaiebet, et al.
Cost Effectiveness and Resource Allocation (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Impact of including boys in the national school-based human papillomavirus vaccination programme in Singapore: A modelling-based cost-effectiveness analysis
Muhammad Taufeeq Wahab, Rayner Kay Jin Tan, Alex R. Cook, et al.
Vaccine (2023) Vol. 41, Iss. 12, pp. 1934-1942
Closed Access | Times Cited: 3
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
Kris Doggen, Albert Jan van Hoek, Jeroen Luyten
PharmacoEconomics (2023) Vol. 41, Iss. 5, pp. 481-497
Closed Access | Times Cited: 2
The Cost-Effectiveness of HPV Vaccination in Asia Pacific Countries: What Lessons Can Indonesia Learn? – A Systematic Review
Suzanna Mongan, Joshua Byrnes, Han‐Soo Kim
(2024)
Closed Access
Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in the Netherlands: a data-driven analysis
Birgit Sollie, Johannes Berkhof, Johannes A. Bogaards
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Nonavalent vaccine for school-based HPV vaccination programme in Singapore: benefits at high cost

PharmacoEconomics & Outcomes News (2021) Vol. 875, Iss. 1, pp. 19-19
Closed Access
Page 1

Scroll to top